Search research articles
Contact Us
Filters
Showing results (731-740 of 777) with videos related to
Page
of 78
Sort By:
Nature Reviews. Gastroenterology & Hepatology
|
April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Hepatology (Baltimore, Md.)
|
July 5, 2019
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M Anstee, Eric J Lawitz, Naim Alkhouri, et al.
Journal of Hepatology
|
July 9, 2021
24-Norursodeoxycholic acid reshapes immunometabolism in CD8<sup>+</sup> T cells and alleviates hepatic inflammation
Ci Zhu, Nicole Boucheron, André C Müller, et al.
Wiener Klinische Wochenschrift
|
June 26, 2023
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Journal of Hepatology
|
December 6, 2021
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
Georg Semmler, Elias Laurin Meyer, Karin Kozbial, et al.
Journal of Hepatology
|
March 10, 2020
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A Harrison, Vincent Wai-Sun Wong, Takeshi Okanoue, et al.
The Lancet. Gastroenterology & Hepatology
|
October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial
Michael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Metabolism: Clinical and Experimental
|
April 9, 2025
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy
Marianna Beghini, Matthäus Metz, Clemens Baumgartner, et al.
Annals of the Rheumatic Diseases
|
November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Journal of Hepatology
|
April 19, 2021
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
Maria Reich, Lina Spomer, Caroline Klindt, et al.
Page
of 78
Search research articles
Search
Showing results (731-740 of 777) with videos related to
Sort By:
Page
of 78
Nature Reviews. Gastroenterology & Hepatology
|
April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Hepatology (Baltimore, Md.)
|
July 5, 2019
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M Anstee, Eric J Lawitz, Naim Alkhouri, et al.
Journal of Hepatology
|
July 9, 2021
24-Norursodeoxycholic acid reshapes immunometabolism in CD8<sup>+</sup> T cells and alleviates hepatic inflammation
Ci Zhu, Nicole Boucheron, André C Müller, et al.
Wiener Klinische Wochenschrift
|
June 26, 2023
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Journal of Hepatology
|
December 6, 2021
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
Georg Semmler, Elias Laurin Meyer, Karin Kozbial, et al.
Journal of Hepatology
|
March 10, 2020
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A Harrison, Vincent Wai-Sun Wong, Takeshi Okanoue, et al.
The Lancet. Gastroenterology & Hepatology
|
October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial
Michael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Metabolism: Clinical and Experimental
|
April 9, 2025
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy
Marianna Beghini, Matthäus Metz, Clemens Baumgartner, et al.
Annals of the Rheumatic Diseases
|
November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Journal of Hepatology
|
April 19, 2021
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
Maria Reich, Lina Spomer, Caroline Klindt, et al.
Page
of 78